
|Videos|October 5, 2020
Botulinum toxin benefits patients with adult neurogenic lower urinary tract dysfunction
Author(s)Urology Times staff
R. Corey O'Connor, MD, discusses findings from a recent study published in Neurourology and Urodynamics.
Advertisement
In this interview, R. Corey O'Connor, MD, discusses the recent Neurourology and Urodynamics paper, “Intradetrusor botulinum toxin injections (300 units) for the treatment of poorly compliant bladders in patients with adult neurogenic lower urinary tract dysfunction," for which he served as a study author. O'Connor is associate professor of urology at the Medical College of Wisconsin, Milwaukee.
More videos:
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
GPS-ProtecT study launched to validate Genomic Prostate Score in active surveillance
2
Permanent J code for mitomycin for intravesical solution now in effect
3
Real-World Evidence in mCSPC Management
4
Pearls & Perspectives: Sexual Health at the Intersection of Urology and Therapy, with Nicoletta Heidegger, MA, MEd, LMFT
5

















